Comparing IL-4 expression in thymocyte selection-associated HMG BOX (TOX)+ CD4+ T-cells between plaque and tumor lesions, a significant increase in IL-4 and TOX expression was observed in the tumor stage, with a positive correlation between the levels of TOX and IL-4 expression. This evidence concerns the gene IL4 and neoplasm.